# Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)

> **NCT00903942** · PHASE2 · WITHDRAWN · sponsor: **University of Rochester**

## Conditions studied

- Non-small Cell Lung Cancer, Stage III

## Interventions

- **RADIATION:** radiation therapy
- **DRUG:** Paclitaxel Protein-Bound, and CARBOPLATIN

## Key facts

- **NCT ID:** NCT00903942
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-03
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** funding was withdrawn from Drug company
- **Last updated:** 2015-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903942, "Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00903942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*